What is the approximate half-life of cabergoline?

Cabergoline (Cabergoline) is a dopamine receptor agonist commonly used to treat hyperprolactinemia. It is widely used in clinical practice because of its good efficacy and low side effects. Its pharmacological effect is mainly through stimulating the D2 dopamine receptors in the anterior pituitary gland, thereby inhibiting the secretion of prolactin (PRL). Compared with other similar drugs, cabergoline has a significant advantage, that is, its longer half-life, which makes its administration less frequent and improves patient compliance.

According to research data, the terminal plasma half-life of cabergoline is approximately 63 to 69 hours, and can even be as long as 115 hours in some individuals. This means that the drug is metabolized and cleared from the body more slowly, and its effect lasts longer. Therefore, in most treatment regimens, cabergoline usually only needs to be taken 1 to 2 times per week to achieve stable therapeutic effects. Compared with traditional drugs such as bromocriptine, cabergoline can significantly reduce the number of times patients take medication, thereby reducing the inconvenience caused by frequent medication.

The long half-life of cabergoline not only helps maintain stable blood concentration, but also reduces fluctuations in serum prolactin, thereby achieving a more stable therapeutic effect. However, precisely because of its slow metabolism, once adverse reactions occur (such as hypotension, nausea, or risk of heart valve disease, etc.), the symptoms may last for a long time. Therefore, use must be monitored and adjusted strictly in accordance with the guidance of a doctor.

In general, the long half-life of cabergoline is an important advantage in the treatment of diseases such as hyperprolactinemia. It can provide sustained and stable drug effects and reduce the frequency of medication, but it also puts forward higher requirements for individualized adjustment of medication. Patients should use this drug under the guidance of a professional doctor, and regularly monitor prolactin levels and heart function to ensure drug safety and efficacy.

Reference materials:https://my.clevelandclinic.org/health/drugs/20863-cabergoline-tablets